Octapharma is committed to improving awareness of bleeding disorders to help patients like Andrew.

Take one day at a time

Octapharma is committed to improving awareness of bleeding disorders to help patients like Andrew.

Watch his story

News & Stories

Positive results from ProDERM study of octagam® 10% in patients with dermatomyositis meeting the primary endpoint will be presented at ACR Convergence 2020

19.10.2020

Press release

Octapharma announces FDA approval of updated NUWIQ

Prescribing Information will include immunogenicity data in previously untreated patients.

Octapharma online lectures

03.02.2021

EAHAD 2021

European Association for Haemophilia and Allied Disorders (EAHAD)

28.11.2020

Euroanaesthesia 2020

Euroanaesthesia presents innovations in anaesthesia and other forms of critical care.

14.10.2020

ESID 2020 online meeting

Watch our symposium on demand to learn about the potential use of immunoglobulin in fighting COVID-19.

Check all our virtual events

Patient Engagement

Octapharma takes an active role in our community

We sponsor and support organisations worldwide.

Learn how we engage with patients

Careers and Jobs

Explore a new world of opportunities

Our global presence offers you a great opportunity to gain international experience. Every employee contributes to the ongoing success of the company.

Working with Octapharma

Take one day at a time

Check out our latest stories

Akron B and Octapharma sign global agreement

Octapharma to demonstrate ongoing commitment

Positive results from ProDERM study of octagam® 10% in patients with dermatomyositis meeting the primary endpoint will be presented at ACR Convergence 2020

Octapharma announces FDA approval of updated NUWIQ

Octapharma online lectures

EAHAD 2021

Euroanaesthesia 2020

ESID 2020 online meeting

Octapharma takes an active role in our community

Explore a new world of opportunities

About us

Plasma

Products

Careers

Engagement

News